BICYCLE THERAPEUTICS PLC

BCYC

Explore Our Financial Data > Companies > BICYCLE THERAPEUTICS PLC

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	BCYC
CIK	0001761612
SIC	2834
Sector	Manufacturing
Industry Category	Pharmaceutical Products
Industry Group	Pharmaceutical Preparations

Contact

Address	BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, X0, CB21 6GS
Website	bicycletherapeutics.com
Phone	011441223261503
CEO	Kevin Lee
Employees	240

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$19.28 million
Pre-Tax Income	$-248.21 million
Net Income	$-242.36 million
Net Income to Common	$-242.36 million
EPS	$-3.53

View All

Balance Sheet

Cash	$721.45 million
Assets	$832.18 million
Liabilities	$163.27 million
Common Equity	$668.92 million
Liabilities & Equity	$832.18 million

View All

Cash Flow Statement

Net Income	$-242.36 million
Cash From Operating Activities	$-208.38 million
Cash From Investing Activities	$-1.90 million
Cash From Financing Activities	$-31.81 million
Change in Cash	$-239.91 million

View All

Calculations

NOPAT	$-201.82 million
EBITDA	$-281.11 million
Price to Earnings	N/A
Price to Book	$0.74
ROE	-31.42%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

European equities traded in the US as American depositary receipts were higher late Wednesday mornin

Article Link